Molecular Human Reproduction, Vol. 6, No. 6, 541-548,
June 2000
© 2000 European Society of Human Reproduction and Embryology
Pregnancy |
The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix
1 Obstetrics and Gynaecology and 2 Medical Research Council Reproductive Biology Unit, University of Edinburgh, Centre for Reproductive Biology, 37 Chalmers Street, Edinburgh, EH3 9ET, UK 3 Department of Maternal and Fetal Medicine, Division of Paediatrics, Obstetrics and Gynaecology, Imperial College School of Medicine, Queen Charlotte's Hospital, London, W6 OXG
Abstract
Cervical ripening is analogous to an inflammatory reaction characterized by an influx of inflammatory cells and an increase in inflammatory mediators. The anti-gestogen mifepristone is highly effective in inducing cervical ripening in women throughout gestation. However, its mechanism of action is largely unknown. The aim of the study was to investigate the effect of in-vivo administration of mifepristone on inflammatory cells and mediators in the cervix. Cervical biopsies were taken from women undergoing a first trimester termination of pregnancy at 0, 6, 12, 24 and 36 h (n = 6 per group) after mifepristone administration. Biopsies were fixed for immunohistochemistry and also cultured for subsequent analysis of culture media by radioimmunoassay or enzyme-linked immunosorbent assay. After administration of mifepristone (6–24 h), there was an increase in immunostaining for leukocyte common antigen (CD45), neutrophil elastase, monocytes (CD68), and matrix metalloproteinases (MMP)-1, -8 and -9. Immunostaining for MMP-2 and tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -4 were unaffected by mifepristone treatment. Secretion of monocyte chemotactic protein (MCP-1) was significantly (P < 0.05) increased from biopsies taken 6–24 h after mifepristone administration. Cervical biopsies also released interleukin-8 (IL-8), prostaglandin (PG) E2, PGF2
and prostaglandin metabolites (PGEM and PGFM) although their secretion was unaffected by mifepristone treatment. This study suggests that mifepristone may, in part, effect cervical ripening by modulating the influx of inflammatory cells into the cervix, up-regulating MMP expression and inducing chemokine secretion by cervical tissue.
cervical ripening/inflammation/leukocyte/mifepristone/pregnancy
Notes
4 To whom correspondence should be addressed at: Obstetrics and Gynaecology, Centre for Reproductive Biology, University of Edinburgh, Centre for Reproductive Biology, 37 Chalmers Street, Edinburgh, EH3 9ET, UK. E-mail: F.Denison{at}ed.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. P Miech Pathopharmacology of Excessive Hemorrhage in Mifepristone Abortions Ann. Pharmacother., December 1, 2007; 41(12): 2002 - 2007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vaisanen-Tommiska, R. Butzow, O. Ylikorkala, and T. S. Mikkola Mifepristone-induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy Hum. Reprod., August 1, 2006; 21(8): 2180 - 2184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Curry Jr. and K. G. Osteen The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle Endocr. Rev., August 1, 2003; 24(4): 428 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cauci, S. Guaschino, D. de Aloysio, S. Driussi, D. De Santo, P. Penacchioni, and F. Quadrifoglio Interrelationships of interleukin-8 with interleukin-1{beta} and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women Mol. Hum. Reprod., January 1, 2003; 9(1): 53 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Stygar, H. Wang, Y. S. Vladic, G. Ekman, H. Eriksson, and L. Sahlin Increased Level of Matrix Metalloproteinases 2 and 9 in the Ripening Process of the Human Cervix Biol Reprod, September 1, 2002; 67(3): 889 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Koumas, A. E. King, H. O. D. Critchley, R. W. Kelly, and R. P. Phipps Fibroblast Heterogeneity : Existence of Functionally Distinct Thy 1+ and Thy 1- Human Female Reproductive Tract Fibroblasts Am. J. Pathol., September 1, 2001; 159(3): 925 - 935. [Abstract] [Full Text] [PDF]
|
|